![AbbVie Appoints Robert A. Michael as CEO](https://i-invdn-com.investing.com/news/World_News_8_150x108_S_1420026210.jpg)
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MEX | TSXV | CAD | Delayed | |
MEX | CBOE Canada | CAD | Real-time |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | ||||
Operating Income | -0.1 | -0.23 | -0.31 | -0.42 |
Net Income | -0.1 | -0.23 | -0.31 | -0.42 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 0.23 | 0.33 | 0.49 | 0.36 |
Total Liabilities | 0.07 | 0.07 | 0.11 | 0.15 |
Total Equity | 0.16 | 0.26 | 0.39 | 0.21 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -0.46 | -0.39 | -0.3 | -3.14 |
Cash From Investing Activities | ||||
Cash From Financing Activities | 0.48 | 0.48 | 0.48 | 1.39 |
Net Change in Cash | 0.03 | 0.1 | 0.19 | -1.74 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review